Novo Nordisk | Capitale Ordinario

Created with Highcharts 10.1.0Chart context menu


Ordinary Share Capital Cambiamento Data
ANI Pharmaceuticals USD 2K 0 2024-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bausch Health Companies USD 10.49B 6M 2024-09
Bristol-Myers Squibb USD 292M 0 2024-12
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Novo Nordisk 446M 0 2024-09
Novo Nordisk DKK 446M 0 2024-09
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Prestige Brands USD 559K 2K 2024-12
Supernus Pharmaceuticals USD 56K 1000 2024-12
Zoetis USD 5M 0 2024-12



Novo Nordisk Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.